AAX Biotech and Daiichi Sankyo partner to evaluate antibody therapeutics
October 31, 2025AAX Biotech, Daiichi Sankyo, Opti-mAb, Seqitope
AAX Biotech, a Swedish biotechnology company specialising in next-generation antibody therapeutics, has launched a strategic partnership with Daiichi Sankyo, a …
Landmark Bio and Mass General Brigham partner to accelerate translational CGT therapies
October 30, 2025Research and Development Landmark Bio, Mass General Brigham, cell and gene therapies, partnership
Landmark Bio and Mass General Brigham in the US have entered a new strategic collaboration designed to accelerate the development …
Is this an Oppenheimer moment for the life sciences industry?
October 29, 2025Business Services, Market Access, Market Access Consultancy, Sales and Marketing NHS, Visions4Health
By Sabina Syed, Managing Director at Visions4Health In the history of science, few initiatives demonstrate the magnitude of coordinated effort …
Pharma&’s ovarian cancer therapy approved for use by NHS Scotland
October 29, 2025Pharma&, Rubraca, Scottish Medicines Consortium, nhs scotland, oncology, ovarian cancer
Pharma& has announced that its treatment for ovarian cancer, Rubraca (rucaparib), has been accepted by the Scottish Medicines Consortium (SMC) …
BioMedX launches R&D accelerator to advance women’s health
October 28, 2025Research and Development BioMedX, Gates Foundation, Women’s Health
BioMed X, an independent research institute with sites in Germany and the United States, has announced the launch of XFem …
Berlin Heals appoints Dr Eric Fain as new board member
October 28, 2025Berlin Heals, Cardiovascular Health, chronic heart failure, medtech
Berlin Heals, a clinical-stage medical device company focused on treating chronic heart failure, has appointed Dr Eric S Fain to …
Turning a 10-Year Vision into a 10-Year Plan
October 27, 2025Business Services, Market Access, Market Access Consultancy Corporate, Gateway to Local Adoption, NHS, Pharmacy, Population Health Management, Visions4Health, pharmacy
In the sixth of the Gateway to Local Adoption series, Visions4Health’s Head of Client Services, Jonny Savage, shares his views …
Sharp invests $100m in US and EU manufacturing and packaging facilities
October 27, 2025Manufacturing and Production EU, Sharp Services, US, manufacturing and packaging
Sharp Services, a pharmaceutical packaging and sterile manufacturing specialist, has announced investments totalling $100m across its US and European facility …
NNIT partners with global biopharma company for regulatory registration management
October 24, 2025Business Services IT, NNIT, digital solutions, regulatory
NNIT, a Danish provider of digital software and IT services, has entered a long-term strategic partnership with a global biopharmaceutical …
THX Pharma and Exeltis announce first milestone achieved for neurological disease treatment
October 23, 2025Research and Development Neurological Diseases, THX Pharma, Theranexus
THX Pharma (Theranexus), a pharma company focusing on developing treatments for rare neurological disease, and Exeltis, a pharma company within …
Excellence in Healthcare Partnerships (EHP) Awards Networking Event
October 23, 2025Medical Communications EHP Awards
From plan to partnership: navigating the enablers and challenges of collaborative working. How has the 10-year healthcare plan and Life …
PolyNovo welcomes Bruce Peatey as CEO
October 22, 2025CEO, Market Expansion, PolyNovo, medtech, wound care
PolyNovo, an Australian medtech company specialising in acute complex wound management, has appointed Bruce Peatey as its new chief executive …
Recipharm offers manufacturing support to vaccine trial from ImmBIO and iiCON
October 21, 2025Manufacturing and Production ImmunBiology, Infection Innovation Consortium, Recipharm, Vaccine, pneumococcal disease
Recipharm, a contract development and manufacturing organisation (CDMO), has successfully manufactured PnuBioVax, a new protein-based vaccine against pneumococcal disease, developed …
IMed Consultancy releases white paper on Digital Mental Health Technologies
October 20, 2025Medical Communications Digital Mental Health Technologies, IMed Consultancy, MHRA
IMed Consultancy, a consultancy and service provider for the medical and health technology sector, has published a new white paper …
Chemify relocates to Glasgow’s new Health Innovation Hub
October 17, 2025Research and Development Chemify, Kadans Science Partner, Scotland
The company will be one of the first tenants in the city’s flagship life sciences facility
Oxford North UK innovation district officially opened
October 16, 2025Research and Development Oxford North, University of Oxford, innovation district
Oxford North, a new innovation district in Oxford, UK, with planning permission for around one million sq ft of newly …
Julius Clinical appoints Bassem Saleh as CEO
October 16, 2025Julius Clinical, cardiometabolic diseases, central nervous system
Julius Clinical, a Netherlands-based clinical research organisation (CRO), has appointed Bassem Saleh as its new chief executive officer (CEO). Saleh …
Alto Neuroscience’s schizophrenia treatment granted FDA Fast Track designation
October 14, 2025Alto Neuroscience, FDA, schizophrenia
Alto Neuroscience has announced that its investigational treatment for cognitive impairment associated with schizophrenia (CIAS) has received Fast Track designation …
FairJourney Biologics appoints Dr Werner Lanthaler as CEO
October 14, 2025FairJourney Biologics
FairJourney Biologics (FJBio), Portuguese antibody discovery and development company, has appointed Dr Werner Lanthaler as its new chief executive officer. …
ANGLE unveils new strategy with executive reshuffle and name change to CelLBx Health
October 13, 2025Business Services Angle
ANGLE has outlined a revised business strategy centred on tighter cost management, accelerated commercial execution, and long-term sustainability. The update …
Latest content
FibroFind appoints Lee Borthwick as CEO
